Beta Bionics, Inc. Common Stock

BBNXNASDAQ • USD
11.43 USD
↘ 0.77 (6.31%)AT CLOSE (11:59 AM EDT)
11.50
↗ 0.07 (0.57%)
POST MARKET (AS OF 07:34 PM EDT)
Post Market
AS OF 07:34 PM EDT
11.50
↗ 0.07 (0.57%)
🔴Market: CLOSED
Open?$12.22
High?$12.22
Low?$11.15
Prev. Close?$12.20
Volume?1.3M
Avg. Volume?1.1M
VWAP?$11.53
Rel. Volume?1.14x
Bid / Ask
Bid?$11.40 × 100
Ask?$11.50 × 100
Spread?$0.10
Midpoint?$11.45
Valuation & Ratios
Market Cap?546.8M
Shares Out?44.6M
Float?37.7M
Float %?84.8%
P/E Ratio?N/A
P/B Ratio?1.90
EPS?-$1.64
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?8.66Strong
Quick Ratio?7.96Strong
Cash Ratio?1.02Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score
83/100
P/E?
N/A▾
P/B?
1.90CHEAP▾
P/S?
5.45FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
-7.4CHEAP▾
EV/Sales?
5.14FAIR▾
Returns & Efficiency
ROE?
-25.5%WEAK▾
ROA?
-22.3%WEAK▾
Cash Flow & Enterprise
FCF?$-56222000
Enterprise Value?$515.2M
Related Companies
DXCMRMDSENSPODDTNDMMMEDIRTCPFSAGCTKMASIEMBCVMD
News
Profile
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
Employees
423
Market Cap
546.8M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
www.betabionics.com
Listed
2025-01-30
Address
11 HUGHES
IRVINE, CA 92618
Phone: 949-427-7785
MarketsMoversWatchlist